The latest closing stock price for Cadrenal Therapeutics as of February 21, 2025 is 19.89.
An investor who bought $1,000 worth of Cadrenal Therapeutics stock at the IPO in 2023 would have $3,828 today, roughly 4 times their original investment - a 119.72% compound annual growth rate over 2 years.
The all-time high Cadrenal Therapeutics stock closing price was 19.89 on January 22, 2025.
The Cadrenal Therapeutics 52-week high stock price is 20.79, which is 4.5% above the current share price.
The Cadrenal Therapeutics 52-week low stock price is 0.36, which is 98.2% below the current share price.
The average Cadrenal Therapeutics stock price for the last 52 weeks is 7.58.
An investor who bought $1,000 worth of Cadrenal Therapeutics stock at the IPO in 2023 would have $3,828 today, roughly 4 times their original investment - a 119.72% compound annual growth rate over 2 years.
The all-time high Cadrenal Therapeutics stock closing price was 19.89 on January 22, 2025.
The Cadrenal Therapeutics 52-week high stock price is 20.79, which is 4.5% above the current share price.
The Cadrenal Therapeutics 52-week low stock price is 0.36, which is 98.2% below the current share price.
The average Cadrenal Therapeutics stock price for the last 52 weeks is 7.58.